| Schedule of changes in stockholders' equity |
Three and Six Months Ended June 30, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | | | | Additional | | Other | | | | | Total | | | Common Stock | | | Paid-In | | Comprehensive | | Accumulated | | Stockholders’ | | | Shares | | Amount | | | Capital | | Loss | | Deficit | | Equity | Balance, March 31, 2026 | | 332,308 | | $ | 33 | | $ | 1,322,119 | | $ | (706) | | $ | (737,848) | | $ | 583,598 | Issuance of common stock upon exercise of stock options | | 391 | | | — | | | 330 | | | — | | | — | | | 330 | Issuance of common stock upon exercise of common stock warrants | | 6 | | | — | | | 138 | | | — | | | — | | | 138 | Issuance of common stock upon release of restricted stock units ("RSUs") | | 972 | | | — | | | — | | | — | | | — | | | — | Stock-based compensation | | — | | | — | | | 7,020 | | | — | | | — | | | 7,020 | Foreign currency translation loss | | — | | | — | | | — | | | (182) | | | — | | | (182) | Change in unrealized loss on available-for-sale securities | | — | | | — | | | — | | | (864) | | | — | | | (864) | Net loss | | — | | | — | | | — | | | — | | | (52,606) | | | (52,606) | Balance, June 30, 2026 | | 333,677 | | $ | 33 | | $ | 1,329,607 | | $ | (1,752) | | $ | (790,454) | | $ | 537,434 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | | | | Additional | | Other | | | | | Total | | | Common Stock | | Paid-In | | Comprehensive | | Accumulated | | Stockholders’ | | | Shares | | Amount | | Capital | | Income (Loss) | | Deficit | | Equity | Balance, December 31, 2025 | | 331,283 | | $ | 33 | | $ | 1,316,126 | | $ | 997 | | $ | (770,957) | | $ | 546,199 | Issuance of common stock upon exercise of stock options | | 419 | | | — | | | 381 | | | — | | | — | | | 381 | Issuance of common stock upon exercise of common stock warrants | | 9 | | | — | | | 190 | | | — | | | — | | | 190 | Issuance of common stock upon release of RSUs | | 1,966 | | | — | | | — | | | — | | | — | | | — | Stock-based compensation | | — | | | — | | | 12,910 | | | — | | | — | | | 12,910 | Foreign currency translation loss | | — | | | — | | | — | | | (573) | | | — | | | (573) | Change in unrealized loss on available-for-sale securities | | — | | | — | | | — | | | (2,176) | | | — | | | (2,176) | Net loss | | — | | | — | | | — | | | — | | | (19,497) | | | (19,497) | Balance, June 30, 2026 | | 333,677 | | $ | 33 | | $ | 1,329,607 | | $ | (1,752) | | $ | (790,454) | | $ | 537,434 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | | | | Additional | | Other | | | | | Total | | | Common Stock | | Paid-In | | Comprehensive | | Accumulated | | Stockholders’ | | | Shares | | Amount | | Capital | | Income (Loss) | | Deficit | | Equity | Balance, March 31, 2025 | | 286,975 | | $ | 29 | | $ | 719,315 | | $ | (88) | | $ | (512,128) | | $ | 207,128 | Issuance of common stock upon exercise of stock options | | 1,297 | | | — | | | 1,116 | | | — | | | — | | | 1,116 | Issuance of common stock upon exercise of common stock warrants | | 10 | | | — | | | 67 | | | — | | | — | | | 67 | Issuance of common stock upon release of RSUs | | 2,150 | | | — | | | — | | | — | | | — | | | — | Proceeds from sale of common stock from Quanta private placement transaction | | 3,020 | | | — | | | 35,000 | | | — | | | — | | | 35,000 | Proceeds from sale of common stock through At-The-Market ("ATM") Offering | | 30,310 | | | 3 | | | 346,716 | | | — | | | — | | | 346,719 | Capitalization of offering costs to equity upon share issuance | | — | | | — | | | (888) | | | — | | | — | | | (888) | Stock-based compensation | | — | | | — | | | 3,554 | | | — | | | — | | | 3,554 | Foreign currency translation gain | | — | | | — | | | — | | | 156 | | | — | | | 156 | Change in unrealized gain on available-for-sale securities | | — | | | — | | | — | | | 65 | | | — | | | 65 | Net loss | | — | | | — | | | — | | | — | | | (39,654) | | | (39,654) | Balance, June 30, 2025 | | 323,762 | | $ | 32 | | $ | 1,104,880 | | $ | 133 | | $ | (551,782) | | $ | 553,263 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | | | | Additional | | Other | | | | | Total | | | Common Stock | | Paid-In | | Comprehensive | | Accumulated | | Stockholders’ | | | Shares | | Amount | | Capital | | Income (Loss) | | Deficit | | Equity | Balance, December 31, 2024 | | 283,547 | | $ | 29 | | $ | 681,202 | | $ | 105 | | $ | (554,747) | | $ | 126,589 | Issuance of common stock upon exercise of stock options | | 1,595 | | | — | | | 1,443 | | | — | | | — | | | 1,443 | Issuance of common stock upon exercise of common stock warrants | | 56 | | | — | | | 733 | | | | | | | | | 733 | Issuance of common stock upon release of RSUs | | 5,234 | | | — | | | — | | | — | | | — | | | — | Proceeds from sale of common stock from Quanta private placement transaction | | 3,020 | | | — | | | 35,000 | | | — | | | — | | | 35,000 | Proceeds from sale of common stock through ATM Offering | | 30,310 | | | 3 | | | 346,716 | | | — | | | — | | | 346,719 | Vesting of Promote Sponsor Vesting Shares | | — | | | — | | | 32,946 | | | | | | | | | 32,946 | Capitalization of deferred offering costs to equity upon share issuance | | — | | | — | | | (888) | | | — | | | — | | | (888) | Stock-based compensation | | — | | | — | | | 7,728 | | | — | | | — | | | 7,728 | Foreign currency translation loss | | — | | | — | | | — | | | (29) | | | — | | | (29) | Change in unrealized gain on available-for-sale securities | | — | | | — | | | — | | | 57 | | | — | | | 57 | Net income | | — | | | — | | | — | | | — | | | 2,965 | | | 2,965 | Balance, June 30, 2025 | | 323,762 | | $ | 32 | | $ | 1,104,880 | | $ | 133 | | $ | (551,782) | | $ | 553,263 |
|